CINECA IRIS Institutional Research Information System

MOSCA, MARTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.317
AS - Asia 12.778
EU - Europa 7.457
SA - Sud America 2.541
AF - Africa 606
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 10
Totale 46.742
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.652
SG - Singapore 4.099
CN - Cina 3.226
IT - Italia 2.236
HK - Hong Kong 2.230
BR - Brasile 2.071
VN - Vietnam 1.457
SE - Svezia 1.151
DE - Germania 764
BG - Bulgaria 758
GB - Regno Unito 507
FR - Francia 462
CA - Canada 458
TR - Turchia 410
FI - Finlandia 374
RU - Federazione Russa 373
IN - India 289
JP - Giappone 220
CI - Costa d'Avorio 195
AR - Argentina 159
UA - Ucraina 153
KR - Corea 130
BD - Bangladesh 119
AT - Austria 108
NL - Olanda 106
ID - Indonesia 101
MX - Messico 101
SN - Senegal 91
IQ - Iraq 88
EC - Ecuador 77
ES - Italia 74
PL - Polonia 71
NG - Nigeria 70
BE - Belgio 63
ZA - Sudafrica 63
MA - Marocco 56
PK - Pakistan 55
CO - Colombia 54
VE - Venezuela 52
CH - Svizzera 44
SA - Arabia Saudita 44
UZ - Uzbekistan 38
PY - Paraguay 36
MY - Malesia 33
EG - Egitto 32
PE - Perù 32
PH - Filippine 31
CL - Cile 30
KE - Kenya 28
LT - Lituania 27
AU - Australia 26
CZ - Repubblica Ceca 23
GR - Grecia 23
PT - Portogallo 22
AE - Emirati Arabi Uniti 20
JO - Giordania 20
AL - Albania 19
IE - Irlanda 18
UY - Uruguay 18
JM - Giamaica 17
RS - Serbia 17
IL - Israele 16
TH - Thailandia 16
CR - Costa Rica 15
KZ - Kazakistan 15
NP - Nepal 15
OM - Oman 15
TN - Tunisia 15
AZ - Azerbaigian 14
DZ - Algeria 14
TT - Trinidad e Tobago 13
IR - Iran 12
DO - Repubblica Dominicana 11
ET - Etiopia 11
BJ - Benin 10
BO - Bolivia 10
RO - Romania 10
TW - Taiwan 10
DK - Danimarca 9
HN - Honduras 8
PA - Panama 8
BY - Bielorussia 7
NZ - Nuova Zelanda 7
BB - Barbados 6
EU - Europa 6
GT - Guatemala 6
LB - Libano 6
SV - El Salvador 6
BH - Bahrain 5
GE - Georgia 5
HR - Croazia 5
KG - Kirghizistan 5
NI - Nicaragua 5
SK - Slovacchia (Repubblica Slovacca) 5
BA - Bosnia-Erzegovina 4
CY - Cipro 4
KW - Kuwait 4
LY - Libia 4
PS - Palestinian Territory 4
SI - Slovenia 4
Totale 46.666
Salva come PNG Salva come JPEG
Città #
Ashburn 2.604
Singapore 2.285
Hong Kong 2.200
Fairfield 1.855
Woodbridge 1.840
Houston 1.323
Dallas 1.301
San Jose 1.276
Ann Arbor 1.225
Santa Clara 1.214
Chandler 1.136
Shanghai 966
Seattle 799
Sofia 752
New York 635
Cambridge 620
Beijing 603
Wilmington 596
Milan 505
Boardman 467
Ho Chi Minh City 425
Los Angeles 344
Ottawa 320
Princeton 316
Lawrence 301
Hanoi 286
Lauterbourg 281
Medford 258
Munich 236
Hefei 211
Abidjan 195
Tokyo 195
Serra 191
Des Moines 188
Izmir 186
Boulder 174
London 174
Florence 166
Nanjing 164
São Paulo 159
Istanbul 154
Council Bluffs 153
Redondo Beach 146
Jacksonville 142
Frankfurt am Main 136
San Diego 128
Seoul 123
Buffalo 119
Dong Ket 119
Pisa 119
Dearborn 117
Turku 103
Dakar 91
Helsinki 88
Rome 85
Bremen 82
Ogden 75
Redwood City 72
Nuremberg 70
Vienna 70
Lancaster 63
Lagos 61
Brussels 56
Da Nang 56
Falls Church 56
Nanchang 55
Columbus 54
Rio de Janeiro 54
Livorno 50
Pune 50
Belo Horizonte 49
Haiphong 48
Chicago 47
Warsaw 45
Kunming 43
Shenyang 43
Changsha 42
Curitiba 41
Montreal 41
Orem 41
The Dalles 41
Fuzhou 40
Norwalk 40
Baghdad 39
Guangzhou 39
Porto Alegre 39
Brooklyn 37
Atlanta 36
Tashkent 36
Brasília 35
Bern 34
Chennai 34
Hebei 34
Toronto 33
Phoenix 32
San Francisco 32
Denver 31
Mumbai 31
Quito 31
Düsseldorf 30
Totale 32.863
Salva come PNG Salva come JPEG
Nome #
Treat-to-target in systemic lupus erythematosus: where are we today? 260
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force 243
Leukopenia, lymphopenia, andneutropenia in systemic lupus erythematosus: Prevalence and clinical impact--A systematic literature review 242
Impact of joint involvement on patients reported outcomes in systemic lupus erythematosus. 236
Depression and systemic lupus erythematosus: a systematic review 227
Insomnia symptoms, perceived stress and coping strategies in patients with systemic lupus erythematosus 211
Gross Cystic Disease Fluid Protein-15(GCDFP-15)/Prolactin-Inducible Protein (PIP) as Functional Salivary Biomarker for Primary Sjögren's Syndrome 204
EXTENSIVE ANALYSIS OF T CELL RECEPTOR GAMMA (TCRG) GENE REARRANGEMENTS REVEALS A SIMILAR REPERTOIRE IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) AND IN HYPEREOSINOPHILIC SYNDROME (HES) 204
Impact of joint involvement on patients reported outcomes in systemic lupus erythematosus 199
Low FODMAP diet: Evidence, doubts, and hopes 193
Minor salivary gland biopsy and Sjögren's syndrome: comparative analysis of biopsies among different Italian rheumatologic centers. 190
TNF-alpha inhibitors in Systemic Lupus Erythematosus. A case report and a systematic literature review 186
TCR GAMMA CLONALITY ASSESSED BY NGS DOES NOT HELP TO DISTINGUISH EGPA FROM HES 184
miRNA-mediated regulation of Mucin-type O-Glycosylation pathway: a putative mechanism of salivary gland dysfunction in Sjögren's syndrome 183
Genetic polymorphisms of thiopurine S-methyltransferase in a cohort of patients with systemic autoimmune diseases 180
Maternal outcome in pregnant women with lupus nephritis. A prospective multicenter study. 180
Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein 179
Treatment with Allogenic Mesenchymal Stromal Cells in a Murine Model of Systemic Lupus Erythematosus 179
Occurrence of hashimoto thyroiditis among the first- and second-degree relatives of systemic lupus erythematosus patients with Hashimoto thyroiditis 179
null 179
Risk factors for osteoporosis and fragility fractures in patients with systemic lupus erythematosus. 178
Assessment of disease activity in systemic lupus erythematosus. 176
Mixed connective tissue disease. 175
Longitudinal adherence trajectories to biologic disease modifying anti-rheumatic drugs in Tuscany, Italy 175
Behçet's disease: features of neurological involvement in a dedicated centre in Italy. 173
In vivo confocal scanning laser microscopy in patients with primary Sjögren's syndrome: A monocentric experience. 172
The role of imaging in the evaluation of joint involvement in 102 consecutive patients with systemic lupus erythematosus 172
Pregnant patient with dermatomyositis successfully treated with intravenous immunoglobulin therapy 171
Muscular vasculitis confined to lower limbs: description of two case reports and a review of the literature 171
Undifferentiated connective tissue diseases (UCTD) 170
Epidemiology and Management of Neuropsychiatric Disorders in Behçet's Syndrome. 170
Fetal outcome and recommendations of pregnancies in lupus nephritis in the 21st century. A prospective multicenter study. 170
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course. 170
Personalization of biologic therapy in patients with rheumatoid arthritis: Less frequently accounted choice-driving variables 168
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study. 167
Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behçet’s syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trial 167
Vascular reactivity in patients with undifferentiated connective tissue diseases 166
Primary anti-phospholipid syndrome: any role for serum complement levels in predicting pregnancy complications? 165
Predictors of renal outcome in diffuse proliferative glomerulonephritis in systemic lupus erythematosus 165
Undifferentiated connective tissue diseases (UCTD): simplified systemic autoimmune diseases 163
The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: Measures of overall disease activity 163
Changes of flow mediated dilation in pregnant patients with systemic autoimmune diseases 162
Rhupus syndrome: Assessment of its prevalence and its clinical and instrumental characteristics in a prospective cohort of 103 SLE patients. 161
The association of Sjögren syndrome and autoimmune thyroid disorders 161
Systemic vasculitis and pregnancy: A multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies 161
Comparison of different forms of Raynaud's phenomenon by LASCA proximal-distal gradient perfusion 160
Platelet GPIIb/IIIa (P1A 1/2) polymorphism in SLE: clinical and laboratory association 160
Validation test for algorithms to identify rheumatoid arthritis patients in the Tuscan healthcare administrative databases 160
Integrated backscatter analysis of carotid intima-media complex in patients with systemic lupus erythematosus 159
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons 159
Occurrence of organ-specific and systemic autoimmune diseases among the first- and second-degree relatives of Caucasian patients with connective tissue diseases: report of data obtained through direct patient interviews 157
Development of a Core Set Questionnaire by the European Society of Cutaneous Lupus Erythematosus (EUSCLE) 157
Prognostic value of flow mediated dilation in patients with systemic lupus erythematosus: A pilot prospective cohort study. 156
Bioelectrical impedance vector analysis in patients with irritable bowel syndrome on a low FODMAP diet: a pilot study 156
Undifferentiated connective tissue diseases (UCTD): Simplified systemic autoimmune diseases 154
Do systemic steroids increase the risk of ocular complication in uveitis patients? Focus on a Italian referral center 154
Undifferentiated connective tissue diseases (UCTD): a new frontier for rheumatology 153
Poor sleep quality in systemic lupus erythematosus: does it depend on depressive symptoms 153
Outcomes, rates and predictors of transition of isolated Raynaud's phenomenon: a systematic review and meta-analysis 153
A low-FODMAP diet for irritable bowel syndrome: Some answers to the doubts from a long-term follow-up 153
UCTD and SLE patients show increased levels of oxidative and DNA damage together with an altered kinetics of DSB repair 153
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study 152
Pediatric Systemic Lupus Erythematosus: Learning From Longer Follow Up to Adulthood. 152
Phenotyping multiple subsets in Sjögren’s syndrome: a salivary proteomic SWATH-MS approach towards precision medicine 152
null 151
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. 151
Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies 150
COVID-19: the new challenge for rheumatologists 150
Systemic lupus erythematosus one disease or many? 149
Risk factors for osteoporosis in female patients with systemic lupus erythematosus 149
Response to interleukin-1 inhibitors in 140 Italian patients with adult-onset still's disease: A multicentre retrospective observational study 149
Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study 148
A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS) 148
Sexual dysfunction in Behçet's syndrome 148
Impact of low-dose acetylsalicylic acid on pregnancy outcome in systemic lupus erythematosus: results from a multicentre study 147
Actigraphic and self-reported characterization of sleep in systemic lupus erythematosus patients 146
[Long term outcome of treatment of diffuse proliferative glomerulonephritis with pulse steroids and short course pulse cyclophosphamide] 146
Alteration of microcirculation is a hallmark of very early systemic sclerosis patients: a laser speckle contrast analysis. 146
Sjögren's syndrome: state of the art on clinical practice guidelines 146
Antiphospholipid syndrome: state of the art on clinical practice guidelines 146
The impact of skin calcinosis on digital ulcers in patients with SSc: clinical and prognostic stratification using the “wound bed score” 146
Assessment of swallowing function with oro-pharyngeal-esophageal scintigraphy in patients with idiopathic inflammatory myopathies 146
Relapsing polychondritis: state of the art on clinical practice guidelines 145
Efficacy of anti-SARS-CoV-2 mRNA vaccine in systemic autoimmune disorders: induction of high avidity and neutralising anti-RBD antibodies 145
clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen 144
Outcome of pregnancy in Italian patients with primary Sjögren syndrome 144
The diagnosis and classification of undifferentiated connective tissue diseases. 144
Post-occlusive reactive hyperaemia (POHR) in systemic sclerosis: very early disease (VEDOSS) represents a separate entity compared to established disease. 144
Psychopathological Impact in Patients with History of Rheumatic Fever with or without Sydenham's Chorea: A Multicenter Prospective Study 143
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome 143
COVID-19 mRNA vaccine booster in patients with autoimmune rheumatic diseases 142
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy 142
The economic impact of gout: a systematic literature review. 142
Changes of flow mediated dilation in pregnant patients with systemic autoimmune diseases. 142
Histopathology of the muscle in rheumatic diseases 142
Multiparametric Skin Assessment in a Monocentric Cohort of Systemic Sclerosis Patients: Is There a Role for Ultra-High Frequency Ultrasound? 141
null 141
Systemic sclerosis chronic ulcers: preliminary results of treatment with allogenic skin grafting in a cohort of Italian patients 141
Systemic lupus erythematosus: state of the art on clinical practice guidelines 141
Cystatin S-a candidate biomarker for severity of submandibular gland involvement in Sjögren's syndrome 140
Totale 16.431
Salva come PNG Salva come JPEG
Categoria #
all - tutte 143.424
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 143.424
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.303 105 154 66 214 608 538 107 161 134 153 208 855
2022/20233.703 523 495 234 325 418 455 54 258 635 23 247 36
2023/20243.117 221 264 302 169 429 598 302 120 66 39 219 388
2024/202511.101 65 409 248 603 864 1.179 1.201 572 1.116 1.501 1.246 2.097
2025/202613.716 854 1.591 1.792 1.677 1.411 1.076 1.930 647 813 1.097 533 295
2026/202799 99 0 0 0 0 0 0 0 0 0 0 0
Totale 47.639